PDUFA Target Action Date is February 28, 2023 SOUTH SAN FRANCISCO, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) Cardiovascular and Renal…Original Article
Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil
